Institutional Ownership
Spruce Biosciences Inc
CUSIP 85209E208COM NEWSPRBQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
21.6%
Max % of class reported
Institutional Holders
31
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Feb 24, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 24, 2026 | Integrated Core Strategies (Us) LLC | 13G | 11.0% | 103.0K | SEC |
| 2 | Feb 18, 2026 | The Carlyle Group Inc. | 13D/A | 4.7% | — | SEC |
| 3 | Feb 17, 2026 | Squadron Master Fund LP | 13G/A | 6.5% | 70.0K | SEC |
| 4 | Feb 17, 2026 | Alyeska Investment Group, L.P. | 13G | 5.8% | 61.7K | SEC |
| 5 | Feb 17, 2026 | Adar1 Capital Management, LLC | 13G | 13.0% | 58.0K | SEC |
| 6 | Feb 17, 2026 | Citadel Advisors LLC | 13G/A | 6.5% | 70.0K | SEC |
| 7 | Feb 10, 2026 | Wellington Management Group LLP | 13G | 5.5% | 58.9K | SEC |
| 8 | Nov 24, 2025 | Boone Peter David Mr | 13G | 6.4% | 68.2K | SEC |
| 9 | Nov 7, 2025 | Ikarian Capital, LLC | 13G/A | 11.4% | 121.4K | SEC |
| 10 | Oct 16, 2025 | Citadel Advisors LLC | 13G | 10.0% | 109.6K | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Spruce Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 121.4K | $7.93M |
| 2 | Millennium Management LLC | 111.9K | $7.31M |
| 3 | Citadel Advisors LLC | 70.0K | $4.57M |
| 4 | Adar1 Capital Management, LLC | 58.6K | $3.83M |
| 5 | Alyeska Investment Group, L.P. | 51.7K | $3.38M |
| 6 | Wellington Management Group LLP | 48.8K | $3.19M |
| 7 | Boothbay Fund Management, LLC | 42.1K | $2.75M |
| 8 | Balyasny Asset Management L.P. | 40.0K | $2.61M |
| 9 | Carlyle Group Inc. | 38.6K | $2.52M |
| 10 | Quinn Opportunity Partners LLC | 26.8K | $1.75M |